Fetal enterovirus syndrome is a rare and serious disease caused by enterovirus infection, which can lead to various pathologies in the fetus during pregnancy. These viruses, penetrating the placental barrier, can cause neurological disorders, cardiovascular abnormalities, and gastrointestinal tract pathologies in the fetus. Clinical signs can appear in both newborns and young children. The main threat of this syndrome is its ability to lead to severe developmental disorders and high morbidity among fetuses, if the mother is infected during pregnancy, especially in the first trimester. The problem of fetal enterovirus syndrome is aggravated by the fact that in the absence of specific therapy, there is a high risk of death or serious complications that can affect the patient's quality of life.
History of the disease and interesting historical facts
The history of fetal enterovirus syndrome goes back several decades. The first mentions of the connection between enterovirus infections and teratogenesis were recorded in the mid-20th century. In the 1980s, a group of researchers led by Dr. John Sullivan conducted a series of epidemiological studies that demonstrated a clear relationship between infection in an elderly mother and changes observed in newborns. Interestingly, back in the early 1960s, as part of research on viral infections, scientists noticed a high percentage of disorders of the central nervous system in children born to mothers who had viral infections during pregnancy. These and other facts led to the intensification of scientific research in this area, which contributed to the development of new methods for diagnosing and treating the syndrome.
Epidemiology
According to the World Health Organization, the incidence of fetal enterovirus syndrome varies in different countries, but the overall epidemiological picture shows a tendency to increase in the number of cases in recent decades. According to statistical reports, the prevalence of this pathology is 0.5-3 cases per 1000 newborns. These figures are mainly observed in regions with a high population concentration and low levels of maternal health. Weakening of the immune system of pregnant women, especially in developing countries, also has a significant impact on the spread of this disease. There are also a number of factors that contribute to an increase in the number of registered cases, such as a seasonal increase in viral infections, as well as a poor sanitary and epidemiological situation.
Genetic predisposition to this disease
To date, it has been established that genetic predisposition to fetal enterovirus syndrome is associated with various mutations in genes responsible for the body's immune response. Among the genes studied, IL6, TNF, and IFNG stand out. Mutations in genes responsible for cellular transport have also been identified, which may determine susceptibility to viral infection during pregnancy. For example, a 2021 study showed that polymorphisms in HLA genes can increase the risk of enterovirus infection, which is confirmed by multiple studies conducted in different localities. Additionally, an analysis of interpopulation differences showed that certain groups have a higher predisposition to the disease, which requires further study of genetic factors in the pathogenesis of this pathology.
Risk factors for the development of this disease
Risk factors for fetal enterovirus syndrome are quite varied and can be both physical and chemical. Physical factors include pregnancy complications and maternal infections such as influenza, staph, and of course enterovirus infections.
Chemical factors include exposure to toxic substances and medications consumed by the pregnant woman, such as antidepressants and some antibiotics, which can have a teratogenic effect.
Also, the following can be indicated as significant risk factors:
- Poor nutrition and lack of vitamins
— Living in unfavorable sanitary and epidemiological conditions
— Stressful situations and psycho-emotional tension in the mother
— Previous miscarriages or complications in previous pregnancies
These factors can be interrelated, aggravating the situation and increasing the risk of pathology in newborns.
Diagnosis of this disease
Diagnosis of fetal enterovirus syndrome is a complex and multi-step process that involves several components. The main symptoms of this syndrome can vary, but the most common are neurological problems such as developmental delays, seizures, and impaired coordination.
Laboratory tests such as polymerase chain reaction (PCR) are used to detect the presence of the virus in the blood of mothers and newborns. Radiological examinations, including ultrasound, are also necessary to determine structural abnormalities in the fetus. It is important to note that the differential diagnosis includes the exclusion of other infectious and genetic diseases.
Against the background of these studies, it is also important to use diagnostic methods such as:
- Fetal biopsy or amniotic fluid
— Molecular genetic tests
- Clinical examination and anamnesis analysis
A comprehensive approach to diagnostics allows us to establish the correct diagnosis and begin appropriate treatment.
Treatment
Treatment of fetal enterovirus syndrome is multi-stage and requires an individual approach. The general strategy includes antiviral therapy and supportive care depending on the severity of clinical symptoms. Pharmacological treatment is based on the use of viral replication inhibitors and immunomodulators, which can significantly reduce the manifestations of the disease.
In some cases, surgery may be necessary to correct anatomical abnormalities caused by the virus's effects on fetal development. Gene therapy approaches that may alter the course of the disease and improve patient outcomes are being actively researched, but are still at an experimental stage.
Other treatments may include physical therapy and the use of rehabilitation programs to improve the patient's quality of life.
List of medications used to treat this disease
The following groups of drugs are used in the treatment of fetal enterovirus syndrome:
- Antiviral drugs: ribavirin, interferons
- Immunomodulators: hyaluronic acid, interleukin preparations
- Symptomatic treatment: anticonvulsants, nonsteroidal anti-inflammatory drugs (NSAIDs)
- Metabolism Correctors: Vitamins and Minerals for Pregnant Women
Strict adherence to the treatment regimen and regular monitoring of the patient’s health are mandatory at each stage of therapy.
Disease monitoring
Monitoring the health of patients with fetal enterovirus syndrome includes ongoing monitoring of the child's development, assessment of neurological and physical functions. Control stages of studies should be carried out at least once every 6 months during the first year of life, then once a year until the age of 3. The prognosis for the disease largely depends on the time of treatment initiation and the severity of clinical manifestations.
Complications can range from mild neurological disorders to severe conditions, which requires regular risk assessment and therapy adjustments depending on the dynamics of the condition. It is important to note that the quality of life of patients can be significantly improved by the correct choice of diagnostic and treatment methods.
Age-related features of the disease
Fetal enterovirus syndrome may present differently depending on the age group. In newborns and infants, neurological abnormalities and physical disabilities are most common, requiring early intervention and rehabilitation. In the 1-5 age group, clinical manifestations may become less pronounced, but adverse effects may persist throughout life.
In older children, the symptoms of the syndrome may be significantly modified, which requires constant monitoring and support from neurologists and other specialists. Thus, the course of the disease is dynamic, and age-related aspects require special attention when determining a rehabilitation plan.
Questions and Answers
- What is fetal enterovirus syndrome? This disease is caused by an infection with enteroviruses that have penetrated the placental barrier, leading to pathologies in the fetus.
- What are the main symptoms of the syndrome? The main symptoms include neurological abnormalities such as seizures and developmental delays, as well as structural abnormalities.
- How is fetal enterovirus syndrome diagnosed? Diagnostics includes a range of studies: ultrasound, PCR, biopsy and clinical examinations.
- What treatment is needed? Treatment includes antiviral drugs, immunomodulators, and possibly surgery to correct anatomical abnormalities.
- What is the risk of complications with this syndrome? Complications can vary and in some cases can lead to serious neurological impairment and reduced quality of life.
Advice from Dr. Oleg Korzhikov:
There are several common questions related to fetal enterovirus syndrome. The first thing to remember is the need for careful monitoring during pregnancy. Pregnant women are advised to avoid contact with people with respiratory infections and to request necessary laboratory tests. In case you already have children who have been diagnosed with the syndrome, take care of regular health checks and early detection of possible disorders. Finally, always monitor your emotions and physical condition. Psycho-emotional health also plays an important role in the successful course of pregnancy and the health of the future baby.
